Top Markets
#1 Islamic Coin Islamic Coin +154.32%
#2 PulseChain PulseChain +49.10%
#3 DogBull DogBull +34.89%
#4 BOOK OF MEME BOOK OF MEME +34.12%
#5 rsERG rsERG +20.54%
#6 Ergo Ergo +19.46%
#7 Bio Protocol Bio Protocol +16.01%
#8 Janction Janction +14.10%
#9 Victoria VR Victoria VR +13.92%
#10 RedStone RedStone +13.84%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
Rank in Stocks #27026
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
Share Price
$2.20
Market Cap
$35.58M
Change (1 day)
2.36%
Change (1 year)
-15.70%
Country
PL
Trade Mabion S.A. (MAB)

Category

Healthcare
Stock split history for Mabion S.A. (MAB)
Mabion S.A. stock (symbol: MAB) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 20, 2026.
One MAB share bought prior to Aug 20, 2026 would equal to 0 MAB shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH